We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
-0.88%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$33.9B
AUM Growth
-$12.9B
(-28%)
Cap. Flow
-$11.3B
Cap. Flow
% of AUM
-33.44%
Top 10 Holdings %
Top 10 Hldgs %
7.18%
Holding
4,846
New
656
Increased
881
Reduced
976
Closed
2,305
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.43% |
| 2 | Healthcare | 14.66% |
| 3 | Industrials | 10.21% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Financials | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESPR
1876
DELISTED
Esperion Therapeutics
ESPR
| $649K | ﹤0.01% |
139,899
-202,748
| -59% | -$870K |
|
|
GTLS
1877
DELISTED
Chart Industries
GTLS
| $649K | ﹤0.01% |
+3,779
| New | +$531K |
|
|
HES
1878
DELISTED
Hess
HES
| $649K | ﹤0.01% |
6,061
-8,659
| -59% | -$821K |
|
|
PHX
1879
DELISTED
PHX Minerals
PHX
| $648K | ﹤0.01% |
211,758
+131,356
| +163% | +$335K |
|
|
MCBC
1880
DELISTED
Macatawa Bank Corp
MCBC
| $646K | ﹤0.01% |
71,713
-25,849
| -26% | -$237K |
|
1881
ADT
ADT
$5.58B
| $644K | ﹤0.01% |
+84,789
| New | +$645K |
|
1882
First Western Financial
MYFW
$306M
| $643K | ﹤0.01% |
20,554
+6,700
| +48% | +$218K |
|
1883
Hanover Insurance
THG
$7.98B
| $643K | ﹤0.01% |
+4,300
| New | +$601K |
|
|
PGTI
1884
DELISTED
PGT, Inc.
PGTI
| $643K | ﹤0.01% |
+35,765
| New | +$724K |
|
1885
SelectQuote
SLQT
$121M
| $642K | ﹤0.01% |
+230,183
| New | +$1.11M |
|
|
AAMI
1886
Acadian Asset Management
AAMI
$3.19B
| $642K | ﹤0.01% |
+26,473
| New | +$629K |
|
1887
Varex Imaging
VREX
$523M
| $640K | ﹤0.01% |
30,046
-272,326
| -90% | -$6.92M |
|
1888
Oportun Financial
OPRT
$372M
| $637K | ﹤0.01% |
44,392
-11,067
| -20% | -$185K |
|
1889
Conagra Brands
CAG
$7.23B
| $635K | ﹤0.01% |
18,910
+2,183
| +13% | +$74.4K |
|
1890
VTEX
VTEX
$713M
| $632K | ﹤0.01% |
+102,773
| New | +$766K |
|
|
IAS
1891
DELISTED
Integral Ad Science
IAS
| $631K | ﹤0.01% |
+45,710
| New | +$779K |
|
1892
Invesco Mortgage Capital
IVR
$805M
| $631K | ﹤0.01% |
27,674
-382,891
| -93% | -$9.42M |
|
|
VERV
1893
DELISTED
Verve Therapeutics
VERV
| $630K | ﹤0.01% |
+27,594
| New | +$789K |
|
|
NFBK
1894
DELISTED
Northfield Bancorp
NFBK
| $629K | ﹤0.01% |
43,809
-9,896
| -18% | -$156K |
|
1895
Enpro
NPO
$7.05B
| $629K | ﹤0.01% |
+6,438
| New | +$685K |
|
|
FFIC
1896
DELISTED
Flushing Financial
FFIC
| $628K | ﹤0.01% |
+28,109
| New | +$671K |
|
1897
Simulations Plus
SLP
$371M
| $628K | ﹤0.01% |
12,319
-36,090
| -75% | -$1.55M |
|
|
LX
1898
LexinFintech Holdings
LX
$241M
| $627K | ﹤0.01% |
239,300
-293,889
| -55% | -$973K |
|
|
SRG
1899
Seritage Growth Properties
SRG
$136M
| $625K | ﹤0.01% |
49,332
+10,353
| +27% | +$114K |
|
|
LUCK
1900
Lucky Strike Entertainment
LUCK
$911M
| $624K | ﹤0.01% |
+58,551
| New | +$542K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2022 Portfolio in Review
As of Q1 2022, Two Sigma Investments held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Two Sigma Investments withdrew a net $11.3B in Q1 2022, closing 2,305 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Two Sigma Investments opened a new position in Cisco worth $223M.
- Two Sigma Investments's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- Two Sigma Investments added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- Two Sigma Investments's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- Two Sigma Investments fully exited Pfizer in Q1 2022, selling an estimated $271M.
- Two Sigma Investments's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- Two Sigma Investments opened 656 new positions and closed 2,305 in Q1 2022.
- Two Sigma Investments's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.